PRESSEMITTEILUNGEN

Düsseldorf (ots) – The rating agency Moody’s changed the outlook for the rating of Gerresheimer from stable to positive and affirmed the Ba2 rating.

Moody’s gave as a reason for the positive change the company’s good operating performance. At the same time Moody’s referred to the strength and stability of the group’s business model.

About Gerresheimer

Gerresheimer is an internationally leading manufacturer of high- quality specialty products made of glass and plastic for the global pharma & healthcare industry. Our wide product spectrum ranges from pharmaceutical vials to complex drug delivery systems, such as syringe systems, insulin pens and inhalers, for safe dosage and application. Together with our partners we develop solutions which set standards and have role-model status throughout their respective business sectors.

Our Group of companies achieves in Europe, North and South America and Asia sales of about E1 billion and employs around 9,400 people. Through top-class technologies, convincing innovations and targeted investments we are systematically expanding our strong market position.

Contact:

Burkhard Lingenberg
Director Corporate Communication & Marketing
Phone +49 211 6181-250
Fax +49 211 6181-241
E-mail b.lingenberg@gerresheimer.com

Investor Relations Contact
Anke Linnartz
Director Investor Relations
Phone +49 211 6181-314
Fax +49 211 6181-121
E-mail a.linnartz@gerresheimer.com

Trackback URL

Agency Moody, Business Model, Business Sectors, Corporate Communication, Drug Delivery Systems, E Mail, Global Pharma, Healthcare Industry, Inhalers, Insulin Pens, Investor Relations, Market Position, Model Status, Ots, Product Spectrum, Role Model, Specialty Products, Strong Market, Syringe, Vials